GOSS Latest Press Releases

-- September 23, 2026 --

Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension Business Wire 4:01 PM

-- September 16, 2026 --

Gossamer Bio Appoints Greg Ciongoli to Board of Directors Business Wire 4:01 PM

-- September 11, 2026 --

Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split Business Wire 8:00 AM

-- September 9, 2026 --

Gossamer Bio Announces 1-for-80 Reverse Stock Split Business Wire 9:00 AM

-- September 4, 2026 --

Gossamer Bio to Present at Cantor Global Healthcare Conference Business Wire 8:00 AM

-- August 21, 2026 --

Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval Business Wire 8:00 AM

-- August 13, 2026 --

Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update Business Wire 4:01 PM

-- August 10, 2026 --

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm PRNewswire 9:24 AM

-- July 27, 2026 --

Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update Business Wire 7:00 AM

-- July 1, 2026 --

Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants Business Wire 9:00 AM

-- June 17, 2026 --

Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes Business Wire 8:00 AM

-- June 3, 2026 --

Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes Business Wire 8:00 AM

-- June 2, 2026 --

Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes Business Wire 8:00 AM

-- June 1, 2026 --

CLASS ACTION DEADLINE TONIGHT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline Business Wire 12:38 PM

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm Business Wire 9:30 AM

GOSS DEADLINE ALERT: Hagens Berman Alerts Gossamer Bio (GOSS) Investors to Today's Lead Plaintiff Deadline in Securities Class Action PRNewswire 5:28 AM

-- May 31, 2026 --

GOSS FINAL DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS Globe Newswire 5:43 PM

GOSS DEADLINE TOMORROW: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action - GOSS Newsfile 12:04 PM

-- May 30, 2026 --

GOSS DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action - GOSS Globe Newswire 6:52 PM

GOSS DEADLINE MONDAY: ROSEN, A LEADING NATIONAL FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action - GOSS Newsfile 11:17 AM

GOSS 2-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS PRNewswire 9:57 AM

-- May 29, 2026 --

GOSSAMER BIO DEADLINE MONDAY JUNE 1st: Bragar Eagel & Squire, P.C. Urges Gossamer Bio, Inc. (NASDAQ:GOSS) Investors with Large Losses to Contact the Firm Before Monday June 1st Globe Newswire 12:52 PM

Deadline Soon: Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit Business Wire 12:00 PM

GOSS FINAL DEADLINE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action - GOSS Newsfile 11:48 AM

GOSS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 PRNewswire 9:35 AM

The Gross Law Firm Reminds Gossamer Bio, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 1, 2026 - GOSS Globe Newswire 9:00 AM

-- May 28, 2026 --

Gossamer Bio Deadline: GOSS Investors with Losses in Excess of $100K Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit PRNewswire 7:10 PM

GOSS 4-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS PRNewswire 9:00 AM

-- May 27, 2026 --

GOSSAMER DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GOSS Globe Newswire 8:15 PM

DEADLINE ALERT for GOSS, NUAI, and MEDP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:07 PM

GOSS INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of the June 1, 2026 Lead Plaintiff Deadline in the Gossamer Bio, Inc. Securities Class Action Globe Newswire 8:00 AM

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 3:42 AM

Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GOSS PRNewswire 1:57 AM

-- May 26, 2026 --

Bragar Eagel & Squire, P.C. Urges Gossamer Bio, Inc. (NASDAQ:GOSS) Investors with Large Losses to Contact the Firm Before Monday June 1st Globe Newswire 5:27 PM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS Globe Newswire 4:06 PM

DEADLINE APPROACHING: Berger Montague Advises Gossamer Bio, Inc. (NASDAQ: GOSS) Investors to Inquire About a Securities Fraud Class Action by June 1, 2026 Globe Newswire 9:37 AM

GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit - Contact The Gross Law Firm PRNewswire 9:00 AM

GOSS 6-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS PRNewswire 8:53 AM

-- May 25, 2026 --

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- HBSS Globe Newswire 11:00 AM

-- May 24, 2026 --

GOSSAMER DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GOSS Globe Newswire 7:25 PM